Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

During the Trading Day
88.94 -3.48 / -3.77%
As of 3:59pm ET
Day’s Change
During After-Hours   Switch to standard view »
88.95 +0.01 / +0.01%
 
Volume: 8.9K

Today’s Trading

Previous close92.42
Today’s open93.21
Day’s range88.16 - 93.99
Volume238,195
Average volume (3 months)409,286
Market cap$1.8B
Dividend yield--
Data as of 3:59pm ET, 09/03/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+88.33%
Earnings growth (next 5 years)+40.00%
Revenue growth (last year)+31.78%
P/E ratio57.3
Price/Sales17.67
Price/Book68.74

Competitors

 Today’s
change
Today’s
% change
LCILannett Company Inc+6.33+12.79%
THRXTheravance Inc+0.53+3.44%
ALDRAlder Biopharmaceuti...-0.74-1.81%
PRTAProthena Corporation...-3.69-6.54%
Data as of 4:01pm ET, 09/03/2015

Financials

Next reporting dateNovember 10, 2015
EPS forecast (this quarter)$0.42
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts

Partner Offers